Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0428
+0.0010 (2.34%)
At close: Feb 27, 2026
Carisma Therapeutics Employees
Carisma Therapeutics had 46 employees as of December 31, 2024. The number of employees decreased by 61 or -57.01% compared to the previous year.
Employees
46
Change (1Y)
-61
Growth (1Y)
-57.01%
Revenue / Employee
$1,144,174
Profits / Employee
$174,826
Market Cap
1.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 46 | -61 | -57.01% |
| Dec 31, 2023 | 107 | 15 | 16.30% |
| Sep 30, 2022 | 92 | - | - |
| Jun 30, 2022 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| Clearside Biomedical | 32 |
| Evofem Biosciences | 32 |
| Vaccinex | 27 |
| ZyVersa Therapeutics | 7 |
Carisma Therapeutics News
- 3 months ago - Carisma Announces Delisting from Nasdaq and SEC Deregistration - PRNewsWire
- 11 months ago - Carisma Therapeutics Provides Corporate Updates - PRNewsWire
- 1 year ago - Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - PRNewsWire
- 1 year ago - Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 1 year ago - Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline - PRNewsWire
- 1 year ago - Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PRNewsWire
- 1 year ago - Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 - PRNewsWire
- 1 year ago - Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma - PRNewsWire